Published
Imunosupresiva inhibitory TNF alfa Infliximab s.c. podání II.
Notice number: 00561939-2026
KEY INFORMATION
- Submission deadline
- • Sep 11, 2026
- Location
- 🇨🇿 Czechia
- Contracting authority
- Institut klinické a experimentální medicíny
- Accepted Languages
- Czech
- Tender type
- Goods
- Contract Value
- Published date
- Aug 13, 2026
TENDER DESCRIPTION
The subject of the public contract is regular supplies of medicinal products for subcutaneous administration containing the active substance infliximab (ATC L04AB02) in the form of a pre-filled pen for the treatment of patients in approved indications according to the SPC valid on the day of submission of tenders. The subject of the public contract is regular supplies of medicinal products for subcutaneous administration containing the active substance infliximab (ATC L04AB02) in the form of a pre-filled pen for the treatment of patients in approved indications according to the SPC valid on the day of submission of tenders.
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 3 FILES
- Submission PortalLINK
- non-restricted-documentLINK
- TED PortalLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.